319 related articles for article (PubMed ID: 7671455)
1. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
2. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
3. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
5. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
6. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
7. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's disease.
Hollister RD; Kisiel W; Hyman BT
Brain Res; 1996 Jul; 728(1):13-9. PubMed ID: 8864292
[TBL] [Abstract][Full Text] [Related]
9. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
10. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain.
Beeson JG; Shelton ER; Chan HW; Gage FH
J Comp Neurol; 1994 Apr; 342(1):69-77. PubMed ID: 8207128
[TBL] [Abstract][Full Text] [Related]
11. Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.
Mochizuki A; Peterson JW; Mufson EJ; Trapp BD
Exp Neurol; 1996 Nov; 142(1):89-102. PubMed ID: 8912901
[TBL] [Abstract][Full Text] [Related]
12. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
13. Neuritic pathology and dementia in Alzheimer's disease.
McKee AC; Kosik KS; Kowall NW
Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
[TBL] [Abstract][Full Text] [Related]
14. APP processing and the APP-KPI domain involvement in the amyloid cascade.
Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease.
Ohgami T; Kitamoto T; Weidmann A; Beyreuther K; Tateishi J
Am J Pathol; 1991 Dec; 139(6):1245-50. PubMed ID: 1684265
[TBL] [Abstract][Full Text] [Related]
16. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.
Oltersdorf T; Fritz LC; Schenk DB; Lieberburg I; Johnson-Wood KL; Beattie EC; Ward PJ; Blacher RW; Dovey HF; Sinha S
Nature; 1989 Sep; 341(6238):144-7. PubMed ID: 2506449
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
18. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
[TBL] [Abstract][Full Text] [Related]
19. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
